Education
About Us
Working with TipRanks
Follow Us
Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
RESEARCH TOOLSreports
Morgan Stanley analyst Michael Ulz has reiterated their bullish stance on AARD stock, giving a Buy rating on March 31. Michael Ulz has given his Buy rating due to a
...Read more
AARD News on the Web
AAII
Neutral
TipRanks News
Neutral
AAII
Neutral
AAII
Neutral
AAII
Neutral
TipRanks News
Neutral
AAII
Neutral
AAII
Neutral
News Score - Last 7 Days
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is AARD’s Media Buzz Sentiment?
Currently, no data Available
What is AARD’s weekly average amount of articles?
Currently, no data Available
What is AARD’s News Sentiment?
50% of articles about AARD were positive this week, compared to its sector average of 57%.